Lilly Plans Raft Of India Launches After Trulicity Success

Lilly’s diabetes drug Trulicity is doing “very well” in India despite a relatively hefty price tag, and the major US company is now planning to ramp up its product launches in this key emerging market as it taps into the growing number of patients moving into higher income brackets.